| Literature DB >> 35111944 |
Melanie Reschke1, Jenna R DiRito2, David Stern2, Wesley Day3, Natalie Plebanek3, Matthew Harris2, Sarah A Hosgood4, Michael L Nicholson4, Danielle J Haakinson2, Xuchen Zhang5, Wajahat Z Mehal6, Xinshou Ouyang6, Jordan S Pober7, W Mark Saltzman3, Gregory T Tietjen2,3.
Abstract
In preclinical research, histological analysis of tissue samples is often limited to qualitative or semiquantitative scoring assessments. The reliability of this analysis can be impaired by the subjectivity of these approaches, even when read by experienced pathologists. Furthermore, the laborious nature of manual image assessments often leads to the analysis being restricted to a relatively small number of images that may not accurately represent the whole sample. Thus, there is a clear need for automated image analysis tools that can provide robust and rapid quantification of histologic samples from paraffin-embedded or cryopreserved tissues. To address this need, we have developed a color image analysis algorithm (DigiPath) to quantify distinct color features in histologic sections. We demonstrate the utility of this tool across multiple types of tissue samples and pathologic features, and compare results from our program to other quantitative approaches such as color thresholding and hand tracing. We believe this tool will enable more thorough and reliable characterization of histological samples to facilitate better rigor and reproducibility in tissue-based analyses.Entities:
Keywords: color image analysis; histology; human organ research; immunohistochemistry
Year: 2021 PMID: 35111944 PMCID: PMC8780932 DOI: 10.1002/btm2.10242
Source DB: PubMed Journal: Bioeng Transl Med ISSN: 2380-6761
FIGURE 1DigiPath is a more efficient method for quantification than hand tracing. (a) Representative image from an H&E section of a kidney during normothermic machine perfusion (NMP). Obstructions are quantified using hand tracing or DigiPath by three individual users (User 1—magenta, User 2—yellow, User 3—cyan). (b) Total area quantified using hand tracing or DigiPath methods from three users. (c) Total time elapsed for hand tracing (circles, black line) or DigiPath (squares, gray line) methods across three users for five separate images. Mixed‐model ANOVA showed a significant difference between the DigiPath and hand tracing cumulative analysis times (**p = 0.0027)
FIGURE 2DigiPath achieves better correlation with hand‐traced standards than color thresholding. (a) Representative images of a human kidney section stained with H&E. Masks of microvascular obstructions were generated by hand tracing (a composite of three independent user tracings), color thresholding and DigiPath (overlays of three independent users: User 1—cyan, User 2—yellow, User 3—magenta). Areas of undercounting (orange arrows) and overcounting (green arrows) from color thresholding are shown. (b) F‐score, Matthews correlation coefficient (MCC), and Youden's J statistic were calculated to measure the correlation of results from thresholding and DigiPath methods with the hand‐traced standard. Lines represent median. **p < 0.01; ****p < 0.0001. Scale bars = 20 μm
FIGURE 3DigiPath enables quantification of multiple histological features across different stains. (a) Representative 20× image fields of three livers with varying degrees of steatosis. Scale bars = 200 μm. Quantification by DigiPath of steatotic area per image field on the right. (b) Representative images of tiled liver biopsies stained with Sirius red. Scale bars = 200 μm. Quantification of Sirius red staining displayed on the right. (c) Representative images of perfused kidneys stained with either H&E (left) or martius scarlet blue (MSB) (right). Scale bars = 100 μm. Overlays show area quantified in a single image. Distribution of positive staining quantified with DigiPath is shown to the right. Each dot represents one field of view. Lines represent the median. Differences between groups are not significant (n.s.) according to a Mann–Whitney test
Human liver demographics
| Age | Donor type | Cause of death | Reason for decline | |
|---|---|---|---|---|
| Liver 1 | 50 | DBD | CVA | Macrovesicular steatosis ~50% with evidence of NASH |
| Liver 2 | 57 | DCD | Arrest from presumed electrolyte abnormalities with pancreatitis | Older DCD with alcohol history, steatosis on imaging and abnormal LFTs (peak bili 1.9) |
| Liver 3 | 36 | DCD | Anoxic arrest (respiratory arrest 2/2 secretions → cardiac arrest) | Slow to progress (extubated 8:55, arrest 9:39, flush 10:13) |
| Liver 4 | 49 | DBD | CVA witnessed at work, progressed to brain death over days with aggressive care | 40%–45% macrovesicular steatosis, moderate inflammation, and stage 2 fibrosis |
| Liver 5 | 29 | DCD | Known brain aneurysm undergoing elective completion stent assisted coiling with intra‐op aneurysm rupture early March. Complex course with acinetobacter in CSF, vasospasm, and arrhythmias | Transaminases sharply rising in 2–5 k range on 3/14, peaked and coming down |
Human kidney demographics
| Age | Donor type | Cause of death | Reason for decline | |
|---|---|---|---|---|
| Kidney 1 | 39 | DBD | Overdose | Suspected malignancy |
| Kidney 2 | 70 | DBD | History of hypertension and diabetes | Stroke |
| Kidney 3 | 70 | DBD | History of hypertension and diabetes | Stroke |
FIGURE 4DigiPath quantifies experimental model of mouse hepatosteatosis. (a) Representative images of tissue from mouse livers on a standard diet (control; left), high fat diet (middle), or high fat diet with a low dose of oral Digoxin (right). Area quantified with DigiPath is shown in green. (b) Quantification of steatotic area in murine models of hepatosteatosis with variable doses of Digoxin. Control group was fed standard chow. Each dot represents an individual image. Red dots correspond to images in (a). Error bars represent the standard error of the mean. Differences between groups are significant according to a Student's t‐test
FIGURE 5DigiPath reveals patterns of cell death in kidney biopsies during cold storage. (a) Representative images of left and right kidneys stained with TUNEL assay after 6 or 72 h on cold storage. Overlays show area quantified after training DigiPath to recognize TUNEL‐positive (brown) or TUNEL‐negative (blue) cells. Scale bars represent 50 μm. (b) Quantification TUNEL staining in left and right kidneys at the beginning and end of cold storage using DigiPath. In (b), the ratio of TUNEL‐positive (brown) cell area to TUNEL‐negative (blue) cell area is plotted. (c) Representative images from immunofluorescence TUNEL staining are presented (red—TUNEL; blue—DAPI). Scale bars represent 50 μm. (d) Quantification of TUNEL staining in left and right kidneys at the beginning and end of cold storage using immunofluorescence. In (d), the number of TUNEL positive cells are divided by the number of DAPI cells. Each dot represents one field of view within the biopsy. Lines represent the median. ****p < 0.0001